Concord Medical Services Holdings Limited
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
18.11-17.98-5.30-3.30-2.95-1.45-1.16-0.67-1.00-1.19-1.98-2.95
Price/Sales ratio
3.722.283.052.833.632.251.620.371.040.662.922.92
Price/Book Value ratio
1.251.011.191.001.58-3.65-0.54-0.13-0.26-0.16-0.70-3.65
Price/Cash Flow ratio
4.60-8.04-17.7935.14-17.98-2.29-1.57-0.51-2.28-1.282.51-17.98
Price/Free Cash Flow ratio
5.93-3.94-7.08-3.58-0.86-0.49-0.49-0.16-0.82-0.903.45-0.86
Price/Earnings Growth ratio
0.560.10-0.02-0.36-0.11-0.02-0.05-0.030.020.030.00-0.11
Dividend Yield
20.07%N/A20.57%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
54.75%42.68%37.02%29.60%10.35%-7.98%5.86%-11.71%-32.28%-14.25%-6.39%-6.39%
Operating Profit Margin
30.26%-0.93%-37.05%-64.00%-156.75%-220.45%-141.69%-94.37%-111.21%-86.15%-215.74%-220.45%
Pretax Profit Margin
28.94%-0.85%-44.96%-76.71%-117.99%-197.15%-198.04%-108.97%-177.91%-103.38%-179.35%-197.15%
Net Profit Margin
20.54%-12.70%-57.54%-85.90%-123.03%-154.79%-139.00%-55.89%-103.72%-55.38%-147.78%-154.79%
Effective Tax Rate
46.03%-1408.92%-29.56%-12.52%-15.11%-9.96%-8.51%-1.24%-8.44%-4.42%1.37%-15.11%
Return on Assets
4.21%-2.17%-8.11%-8.20%-5.12%-7.14%-5.81%-4.35%-8.15%-4.91%-8.59%-7.14%
Return On Equity
6.93%-5.63%-22.45%-30.43%-53.69%250.11%46.75%19.81%26.26%14.02%47.98%-53.69%
Return on Capital Employed
8.38%-0.25%-7.40%-8.98%-8.05%-11.91%-6.55%-8.44%-10.75%-11.28%-14.41%-11.91%
Liquidity Ratios
Current Ratio
1.900.991.251.001.410.451.32N/AN/AN/A0.710.45
Quick Ratio
1.890.981.250.991.400.441.270.670.600.290.200.44
Cash ratio
0.620.370.190.080.460.110.650.190.140.020.090.11
Days of Sales Outstanding
341.06227.07199.44166.35222.76200.51167.6298.15100.7249.9192.30200.51
Days of Inventory outstanding
3.964.027.549.847.157.3937.5725.6249.5823.9865.247.15
Operating Cycle
345.03231.10206.99176.20229.91207.91205.20123.77150.3073.9088.00207.91
Days of Payables Outstanding
1.410.832.597.1411.5914.1032.3968.9685.7776.82100.7311.59
Cash Conversion Cycle
343.61230.26204.39169.05218.32193.80172.8054.8164.53-2.927.65193.80
Debt Ratios
Debt Ratio
0.300.420.360.450.210.300.390.350.500.500.600.21
Debt Equity Ratio
0.501.091.011.702.21-10.52-3.19-1.61-1.61-1.44-2.49-10.52
Long-term Debt to Capitalization
0.150.360.280.460.621.101.502.653.97-18.662.280.62
Total Debt to Capitalization
0.330.520.500.630.681.101.452.622.633.271.980.68
Interest Coverage Ratio
21.30-5.16-13.10-11.06-44.00-106.34-3.77N/AN/AN/A-14.67-44.00
Cash Flow to Debt Ratio
0.54-0.11-0.060.01-0.03-0.15-0.10-0.16-0.07-0.090.13-0.03
Company Equity Multiplier
1.642.582.763.7110.48-35.00-8.04-4.54-3.22-2.85-4.11-4.11
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.80-0.28-0.170.08-0.20-0.98-1.03-0.73-0.45-0.511.16-0.20
Free Cash Flow / Operating Cash Flow Ratio
0.772.032.51-9.8120.804.583.193.112.771.410.724.58
Cash Flow Coverage Ratio
0.54-0.11-0.060.01-0.03-0.15-0.10-0.16-0.07-0.090.13-0.03
Short Term Coverage Ratio
0.86-0.24-0.100.03-0.15N/A-1.54-24.56-0.42-0.261.19-0.15
Dividend Payout Ratio
363.69%N/A-109.15%N/AN/AN/AN/AN/AN/AN/AN/AN/A